Active ingredient
Atogepant
3 finished FDA listings contain Atogepant as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ATOGEPANT, ATOGEPANT MONOHYDRATE
- Dosage forms
- Tablet
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 10 mg/1 · 30 mg/1 · 60 mg/1
- Brand names in FDA listings
- Qulipta
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2571813
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 215206 | ABBVIE | 2021-09-28 | 3 |
Official labeling on DailyMed
- QULIPTA (ATOGEPANT) TABLET [ABBVIE INC.] · version 19 · 2026-02-10
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.